Alcon AG reported $31.62B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
AstraZeneca USD 115.83B 1.82B Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
Essilor EUR 65.06B 1.16B Jun/2026
Fresenius EUR 42.37B 975M Mar/2026
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GRIFOLS EUR 20.09B 12M Jun/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 122.03B 3.5B Jun/2026
Philips EUR 26.7B 565M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Smith & Nephew USD 11.01B 321M Jun/2026
Sonova Holding CHF 5.92B 468.2M Jun/2025
UCB EUR 18.16B 971M Dec/2025